TRPA1 as Target in Myocardial Infarction

Area of Science:

• Cardiology
• Neuroscience
• Ion Channel Physiology

Background:

• Transient receptor potential cation channel subfamily A member 1 (TRPA1) is expressed on sensory neurons and activated by myocardial infarction indicators.
• TRPA1's role in myocardial infarction pathogenesis and its potential as a therapeutic target remain unclear.

Purpose of the Study:

• To investigate the effect of TRPA1 activation, inhibition, or absence on myocardial infarct size.
• To explore the underlying mechanisms of TRPA1's influence on myocardial infarction and cardiomyocyte survival.

Main Methods:

• In vivo studies involved administering TRPA1 agonists or antagonists to rats undergoing myocardial infarction and assessing infarct size.
• TRPA1 knockout mice were compared to wild-type mice.
• In vitro experiments co-cultured sensory neurons with cardiomyocytes subjected to ischemia-reperfusion.

Main Results:

• No significant differences in infarct size were observed in rats treated with TRPA1 modulators or in TRPA1 knockout mice compared to controls.
• In vitro, the presence of sensory neurons significantly increased cardiomyocyte survival probability after ischemia-reperfusion, partly mediated by TRPA1.
• TRPA1 activation or inhibition did not lead to relevant infarct size enlargement in vivo.

Conclusions:

• TRPA1 does not appear to be a promising therapeutic target for reducing myocardial damage within a 24-hour period post-infarction.
• TRPA1's role in sensory neurons may offer partial protection to cardiomyocytes during ischemia-reperfusion, suggesting a localized protective effect.
• The findings argue against adverse effects of TRPA1 targeting for other indications due to its lack of impact on infarct size.